Joan Genescà Ferrer Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine. Institutions of which they are part Head of group Liver Diseases Vall Hebron Institut de Recerca Hepatologia General Hospital Twitter Orcid Joan Genescà Ferrer Twitter Orcid Institutions of which they are part Head of group Liver Diseases Vall Hebron Institut de Recerca Hepatologia General Hospital Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.
Projects Partida para intensificació durant la 2a i 3a anualitat IP: Joan Genescà Ferrer Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 60000 Reference: PI18/00947_INT_GENESCA Duration: 02/03/2020 - 30/06/2023 Targeted biodegradable nanoparticles of simvastatin as new therapeutic tool for chronic liver disease IP: Joan Genescà Ferrer Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 80598 Reference: CD19/00049 Duration: 01/01/2020 - 18/04/2022 BIODEGRADABLE NANOPARTICLES OF SIMVASTATIN AS NEW THERAPEUTIC TOOL FOR CHRONIC LIVER DISEASE (NANOSIM) IP: Joan Genescà Ferrer Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 199952 Reference: ISCIII/EURONANOMED/2018/NANOSIM/DUP Duration: 22/10/2018 - 22/10/2018 BIODEGRADABLE NANOPARTICLES OF SIMVASTATIN AS NEW THERAPEUTIC TOOL FOR CHRONIC LIVER DISEASE (NANOSIM) IP: Joan Genescà Ferrer Collaborators: BIODEGRADABLE NANOPARTICLES OF SIMVASTATIN AS NEW THERAPEUTIC TOOL FOR CHRONIC LIVER DISEASE (NANOSIM), Diana Fernandes de Rafael Funding agency: Instituto de Salud Carlos III Funding: 199946.45 Reference: AC18/00033 Duration: 01/01/2019 - 31/12/2022 Pagination First page « Previous page ‹ Page 1 Page 2 Current page 3 Page 4 Page 5 … Next page › Last page »
